Impact and treatment of cancer during pregnancy

Expert Review of Anticancer Therapy

Volumn 4, Issue 5, 2004, Pages 889-902

  Weisz, Boaz ^a   Meirow, Dror ^a   Schiff, Eyal ^a,b   Lishner, Michael ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Cervical carcinoma; Lymphoma; Malignancy; Malignant melanoma; Pregnancy

Indexed keywords

ALKYLATING AGENT; ALPHA2B INTERFERON; AMINOPTERIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CHLORAMBUCIL; CHLORMETHINE; CHLOROETHYLNITROSOUREA; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; IDARUBICIN; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MISOPROSTOL; PACLITAXEL; PLATINUM DERIVATIVE; THIOTEPA; VINBLASTINE; VINCRISTINE;

BLOOD PLACENTA BARRIER; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHEMICAL TERATOGENESIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FETUS; FETUS MALFORMATION; FETUS MONITORING; FLU LIKE SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; IONIZING RADIATION; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NEEDLE BIOPSY; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; RADIATION INJURY; REVIEW; TERATOGENICITY; TREATMENT PLANNING; UTERINE CERVIX CANCER;

EID: 5444255003     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.4.5.889     Document Type: Review

References (158)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J. Clin. 53(1), 5-26 (2003).
2. Kennedy S, Yudkin P, Greenall M. Cancer in pregnancy. Eur. J. Surg. Oncol. 19(5), 405-407 (1993).
3. Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J. Clin. 50(5), 312-336 (2000).
4. Sorosky JI, Scott-Conner CE. Breast disease complicating pregnancy. Obstet. Gynecol. Clin. North Am. 25(2), 353-363 (1998).
5. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 7(4), 279-287 (2002).
6. Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin. Pharmacokinet. 28(3), 235-269 (1995).
7. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin. Oncol. 16(5), 337-346 (1989).
8. Schenker JG, Meirow D. Pharmacokinetics of the maternal fetal unit. In: The fetus As A Patient. Cagnazzo G, D'Addario V (Eds), Excerpta Medica, Amsterdam, The Netherlands (1989).
9. Witt KL, Bishop JB. Mutagenicity of anticancer drugs in mammalian germ cells. Mutat. Res. 355(1-2), 209-234 (1996).
10. Green DM, Zevon MA, Lowrie G, Seigelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N. Engl. J. Med. 325(3), 141-146 (1991).
11. Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7), 3045-3052 (1996).
12. Sadler TW, Langman J. Langman's Medical Embryology. Lippincott Williams & Wilkins, MD, USA (2004).
13. Schardein JL. Chemically Induced Birth Defects, third edition. Marcel Dekker, Inc., NY, USA (2000).
14. Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet. Gynecol. Clin. North Am. 25(2), 323-329 (1998).
15. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 152(3), 573-576 (1992).
16. Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin. Oncol. 16(5), 388-396 (1989).
17. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch. Intern. Med. 148(9), 2058-2064 (1988).
18. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 269(3), 323 (1993).
19. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann. Oncol. 15(1 , 146-150 (2004).
20. Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet. Gynecol. 18(1), 62-66 (2001).
21. Aviles A, Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med. Pediatr. Oncol. 16(1), 3-6 (1988).
22. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am. J. Hematol. 36(4), 243-248 (1991).
23. Boffetta P, Kaldor JM. Secondary malignancies following cancer chemotherapy. Acta Oncol. 33(6), 591-598 (1994).
24. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin. Lymphoma 2(3), 173-177 (2001).
25. Ward RM, Beachy JC. Neonatal complications following preterm birth. Br. J. Obstet. Gynaecol. 110 (Suppl. 20), 8-16 (2003).
26. Brent RL, Mettler FA. Pregnancy policy. AJR Am. J. Roentgenol. 182(3), 819-822 (2004).
27. Brent RL. Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and postconception environmental radiation exposures. Teratology 59(4 , 182-204 (1999).
28. El Khoury GY, Madsen MT, Blake ME, Yankowitz J. A new pregnancy policy for a new era. AJR Am. J. Roentgenol. 181(2), 335-340 (2003).
29. Pils S, Muller WU, Streffer C. Lethal and teratogenic effects in two successive generations of the HLG mouse strain after radiation exposure of zygotes - association with genomic instability? Mutat. Res. 429(1), 85-92 (1999).
30. Fattibene P, Mazzei F, Nuccetelli C, Risica S. Prenatal exposure to ionizing radiation: sources, effects and regulatory aspects. Acta Pediatr. 88(7), 693-702 (1999).
31. Miller RW. Discussion: severe mental retardation and cancer among atomic bomb survivors exposed in utero. Teratology 59(4), 234-235 (1999).
32. Schull WJ, Otake M. Cognitive function and prenatal exposure to ionizing radiation. Teratology 59(4), 222-226 (1999).
33. Mole RH. The biology and radiobiology of in utero development in relation to radiological protection. Br. J. Radiol. 66(792), 1095-1102 (1993).
34. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 70, 130-139 (1997).
35. Nevin J, Soeters R, Dehaeck K, Bloch B, Van Wyk L. Cervical carcinoma associated with pregnancy. Obstet. Gynecol. Surv. 50(3), 228-239 (1995).
36. Norstrom A, Jansson I, Andersson H. Carcinoma of the uterine cervix in pregnancy. A study of the incidence and treatment in the western region of Sweden 1973 to 1992. Acta Obstet. Gynecol. Scand. 76(6), 583-589 (1997).
37. Hacker NF, Berek JS, Lagasse LD, Charles EH, Savage EW, Moore JG. Carcinoma of the cervix associated with pregnancy. Obstet. Gynecol. 59(6), 735-746 (1982).
38. Duggan B, Muderspach LI, Roman LD, Curtin JP, d'Ablaing G III, Morrow CP. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet. Gynecol. 82(4 Pt 1), 598-602 (1993).
39. Sivanesaratnam V, Jayalakshmi P, Loo C. Surgical management of early invasive cancer of the cervix associated with pregnancy. Gynecol. Oncol. 48(1), 68-75 (1993).
40. Jones WB, Shingleton HM, Russell A et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 77(8), 1479-1488 (1996).
41. Lee RB, Neglia W, Park RC. Cervical carcinoma in pregnancy. Obstet. Gynecol. 58(5), 584-589 (1981).
42. Method MW, Brost BC. Management of cervical cancer in pregnancy. Semin. Surg. Oncol. 16(3), 251-260 (1999).
43. Economos K, Perez VN, Delke I, Collado ML, Tancer ML. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet. Gynecol. 81(6), 915-918 (1993).
44. Sood AK, Sorosky JI, Krogman S, Anderson B, Benda J, Buller RE. Surgical management of cervical cancer complicating pregnancy: a case-control study. Gynecol. Oncol. 63(3), 294-298 (1996).
45. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J. Clin. Oncol. 9(11), 1956-1961 (1991).
46. Prem KA, Makowski EL, McKelvey JL. Carcinoma of the cervix associated with pregnancy. Am. J Obstet. Gynecol. 95(1), 99-108 (1966).
47. Thompson JD, Caputo TA, Franklin EW III, Dale E. The surgical management of invasive cancer of the cervix in pregnancy. Am. J. Obstet. Gynecol. 121(6), 853-863 (1975).
48. Greer BE, Easterling TR, McLennan DA et al. Fetal and maternal considerations in the management of Stage IB cervical cancer during pregnancy. Gynecol. Oncol. 34(1), 61-65 (1989).
49. Hopkins MP, Morley GW. The prognosis and management of cervical cancer associated with pregnancy. Obstet. Gynecol. 80(1), 9-13 (1992).
50. Monk BJ, Montz FJ. Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomy. Obstet. Gynecol. 80(2), 199-203 (1992).
51. Sorosky JI, Squatrito R, Ndubisi BU et al. Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol. Oncol. 59(2), 207-210 (1995).
52. Hopkins MP, Lavin JP. Cervical cancer in pregnancy. Gynecol. Oncol. 63(3), 293 (1996).
53. Hertel H, Possover M, Kulme-Heid R, Schneider A. Laparoscopic lymph node staging of cervical cancer in the 19th week of pregnancy. A case report. Surg. Endosc. 15(3), 324 (2001).
54. Tewari K, Cappuccini F, Balderston KD, Rose GS, Porto M, Berman ML. Pregnancy in a Jehovah's witness with cervical cancer and anemia. Gynecol. Oncol. 71(2), 330-332 (1998).
55. Giacalone PL, Laffargue F, Benos P, Rousseau O, Hedon B. Cisplatinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br. J. Obstet. Gynaecol. 103(9), 932-934 (1996).
56. Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet. Gynecol. 84(2), 179-182 (1994).
57. van der Vange N, Weverling GJ, Kerting BW, Ankum WM, Samlal R, Lammes FB. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet. Gynecol. 85(6), 1022-1026 (1995).
58. Ostrom K, Ben Arie A, Edwards C, Gregg A, Chiu JK , Kaplan AL. Uterine evacuation with misoprostol during radiotherapy for cervical cancer in pregnancy. Int. J. Gynecol. Cancer 13(3), 340-343 (2003 ).
59. Sood AK, Sorosky JI, Mayr N et al. Radiotherapeutic management of cervical carcinoma that complicates pregnancy. Cancer 80(6), 1073-1078 (1997).
60. Bosch A, Marcial VA. Carcinoma of the uterine cervix associated with pregnancy. Am. J. Roentgenol. Radium. Ther. Nucl. Med. 96(1), 92-99 (1966).
61. Rugo HS. Management of breast cancer diagnosed during pregnancy. Curr. Treat. Options Oncol. 4(2), 165-173 (2003).
62. Anderson JM. Mammary cancers and pregnancy. Br. Med. J. 1(6171), 1124-1127 (1979).
63. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am. J. Obstet. Gynecol. 184(7), 1504-1512 (2001).
64. Parente JT, Amsel M, Lerner R, Chinea F. Breast cancer associated with pregnancy. Obstet. Gynecol. 71(6 Pt 1), 861-864 (1988).
65. DiFronzo LA, O'Connell TX. Breast cancer in pregnancy and lactation. Surg. Clin. North Am. 76(2), 267-278 (1996).
66. Gallenberg MM, Loprinzi CL. Breast cancer and pregnancy. Semin. Oncol. 16(5), 369-376 (1989).
67. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 67(4), 869-872 (1991).
68. Bottles K, Taylor RN. Diagnosis of breast masses in pregnant and lactating women by aspiration cytology. Obstet. Gynecol. 66(Suppl. 3), 76S-78S (1985).
69. Ishida T, Yokoe T, Kasumi F et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn. J. Cancer Res. 83(11), 1143-1149 (1992).
70. Mitre BK, Kanbour AI, Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol. 41(4), 1121-1130 (1997).
71. Harbert JC, Rocha L, Smith FP, Delgado G. The efficacy of radionuclide liver and bone scans in the evaluation of gynecologic cancers. Cancer 49(5), 1040-1042 (1982).
72. Fiorica JV. Special problems. Breast cancer and pregnancy. Obstet. Gynecol. Clin. North Am. 21(4), 721-732 (1994).
73. Lauenstein TC, Freudenberg LS, Goehde SC et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur. Radiol. 12(8), 2091-2099 (2002).
74. Nugent P, O'Connell TX. Breast cancer and pregnancy. Arch. Surg. 120(11), 1221-1224 (1985).
75. Ribeiro G, Jones DA, Jones M. Carcinoma of the breast associated with pregnancy. Br. J. Surg. 73(8), 607-609 (1986).
76. Zemlickis D, Lishner M, Degendorfer P et al. Maternal and fetal outcome after breast cancer in pregnancy. Am. J. Obstet. Gynecol. 166(3), 781-787 (1992).
77. Reed W, Sandstad B, Holm R, Nesland JM. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int. J. Surg. Pathol. 11 (2), 65-74 (2003).
78. Hindle W, Gonzalez S. Diagnosis and treatment of invasive breast cancer during pregnancy and lactation. Clin. Obstet. Gynecol. 45(3), 770-773 (2002).
79. Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 71(8), 2499-2506 (1993).
80. Marchant DJ. Breast cancer in pregnancy. Clin. Obstet. Gynecol. 37(4), 993-997 (1994).
81. Keleher AJ, Theriault RL, Gwyn KM et al. Multidisciplinary management of breast cancer concurrent with pregnancy. J. Am. Coll. Surg. 194(1), 54-64 (2002).
82. Merkel DE. Pregnancy and breast cancer. Semin. Surg. Oncol. 12(5), 370-375 (1996).
83. Byrd BF Jr, Stephenson SE, Burch JC, Sawyers JL, Tinsley EA. Type of mastectomy in cancer of the breast: analysis of 1765 cases. Ann. Surg. 163(5), 746-750 (1966).
84. Singletary SE. New approaches to surgery for breast cancer. Endocr. Relat. Cancer 8 (4), 265-286 (2001).
85. Krontiras H, Bland KI. When is sentinel node biopsy for breast cancer contraindicated? Surg. Oncol. 12(3), 207-210 (2003).
86. Morita ET. Lymphoscintigraphy in the detection of sentinel lymph nodes. Cancer Treat. Res. 111, 9-37 (2002).
87. Fisher B, Redmond C, Brown A et al. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project trial. J. Clin. Oncol. 4(4), 459-471 (1986).
88. Kuerer HM, Gwyn K, Ames FC, Theriault RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131(1), 108-110 (2002).
89. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol. Ther. 74(2), 207-220 (1997).
90. Leslie KK. Chemotherapy and pregnancy. Clin. Obstet. Gynecol. 45(1), 153-164 (2002).
91. Berry DL, Theriault RL, Holmes FA et al. Management of breast cancer during pregnancy using a standardized protocol. J. Clin. Oncol. 17(3), 855-861 (1999).
92. d'Incalci M, Broggini M, Buscaglia M, Pardi G. Transplacental passage of doxorubicin. Lancet 1(8314-1315), 75 (1983).
93. Nulman I, Laslo D, Fried S, Uleryk E, Lishner M, Koren G. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br. J. Cancer 85 (11), 1611-1618 (2001).
94. Halakivi-Clarke L, Cho E, Onojafe I, Liao DJ, Clarke R. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin. Cancer Res. 6(1), 305-308 (2000).
95. Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 350(9072), 183 (1997).
96. Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy - case report and literature review. Gynecol. Oncol. 80(3), 405-408 (2001).
97. Dildy GA III, Moise KJ Jr, Carpenter RJ Jr, Klima T. Maternal malignancy metastatic to the products of conception: a review. Obstet. Gynecol. Surv. 44(7), 535-540 (1989).
98. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J. Am. Acad. Dermatol. 34(5 Pt 1), 839-847 (1996).
99. Colbourn DS, Nathanson L, Belilos E. Pregnancy and malignant melanoma. Semin. Oncol. 16(5), 377-387 (1989).
100. Potter JF, Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer 25(2), 380-388 (1970).
101. George PA, Fortner JG, Pack GT. Melanoma with pregnancy. A report of 115 cases. Cancer 13, 854-859 (1960).
102. Grin CM, Driscoll MS, Grant-Kels JM. Pregnancy and the prognosis of malignant melanoma. Semin. Oncol. 23(6), 734-736 (1996).
103. Houghton AN, Flannery J, Viola MV. Malignant melanoma of the skin occurring during pregnancy. Cancer 48(2), 407-410 (1981).
104. Sutherland CM, Loutfi A, Mather FJ, Carter RD, Krementz ET. Effect of pregnancy upon malignant melanoma. Surg. Gynecol. Obstet. 157(5), 443-446 (1983).
105. Shiu MH, Schottenfeld D, Maclean B, Fortner JG. Adverse effect of pregnancy on melanoma: a reappraisal. Cancer 37(1), 181-187 (1976).
106. McManamny DS, Moss AL, Pocock PV, Briggs JC. Melanoma and pregnancy: a long-term follow-up. Br. J. Obstet. Gynaecol. 96(12), 1419-1423 (1989).
107. Wong JH, Sterns EE, Kopald KH, Nizze JA, Morton DL. Prognostic significance of pregnancy in Stage I melanoma. Arch. Surg. 124(10), 1227-1230 (1989).
108. Wong DJ, Strassner HT. Melanoma in pregnancy. Clin. Obstet. Gynecol. 33(4), 782-791 (1990).
109. MacKie RM, Bufalino R, Morabito A, Sutherland C, Cascinelli N. Lack of effect of pregnancy on outcome of melanoma. For the World Health Organization Melanoma Program. Lancet 337(8742), 653-655 (1991).
110. Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ. Pregnancy and early-stage melanoma. Cancer 97(9), 2248-2253 (2003).
111. Reintgen DS, McCarty KS Jr, Vollmer R, Cox E, Seigler HF. Malignant melanoma and pregnancy. Cancer 55(6), 1340-1344 (1985).
112. Slingluff CL Jr, Reintgen DS, Vollmer RT, Seigler HF. Malignant melanoma arising during pregnancy. A study of 100 patients. Ann. Surg. 211(5), 552-557 (1990).
113. Veronesi U, Cascinelli N, Adamus J et al. Thin Stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N. Engl. J. Med. 318(18), 1159-1162 (1988).
114. Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch. Surg. 126(4), 438-441 (1991).
115. Krag DN, Meijer SJ, Weaver DL et al. Minimal-access surgery for staging of malignant melanoma. Arch. Surg. 130(6), 654-658 (1995).
116. Wornom IL III, Smith JW, Soong SJ, McElvein R, Urist MM, Balch CM. Surgery as palliative treatment for distant metastases of melanoma. Ann. Surg. 204(2), 181-185 (1986).
117. 2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J. Clin. Oncol. 14(1), 7-17 (1996).
118. Baer MR. Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with α-interferon. Am. J. Hematol. 37(1), 66 (1991).
119. Sakata H, Karamitsos J, Kundaria B, DiSaia PJ. Case report of interferon-α therapy for multiple myeloma during pregnancy. Am. J. Obstet. Gynecol. 172(1 Pt 1), 217-219 (1995).
120. Brossard J, Abish S, Bernstein ML, Baruchel S, Kovacs L, Pollack R. Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma. Am. J. Pediatr. Hematol. Oncol. 16(4), 380-383 (1994).
121. Haas JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int. J. Cancer 34(2), 229-235 (1984).
122. Ward FT, Weiss RB. Lymphoma and pregnancy. Semin. Oncol. 16(5), 397-409 (1989).
123. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br. J. Cancer 65(1), 114-117 (1992).
124. Barry RM, Diamond HD, Craver LF. Influence of pregnancy on the course of Hodgkin's disease. Am. J. Obstet. Gynecol. 84, 445-454 (1962).
125. Gobbi PG, Attardo-Parrinello A, Danesino M et al. Hodgkin's disease and pregnancy. Haematologica 69(3), 336-341 (1984).
126. Nisce LZ, Tome MA, He S, Lee BJ III, Kutcher GJ. Management of coexisting Hodgkin's disease and pregnancy. Am. J. Clin. Oncol. 9(2), 146-151 (1986).
127. Koren G, Lishner M, Farine D. Cancer in Pregnancy: Maternal and Fetal Risks. Cambridge University Press, Cambridge, UK (1996).
128. Peleg D, Ben Ami M. Lymphoma and leukemia complicating pregnancy. Obstet. Gynecol. Clin. North Am. 25(2), 365-383 (1998).
129. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann. Intern. Med. 95(6), 669-675 (1981).
130. Gelb AB, van de Rijn M, Warnke RA, Kamel OW. Pregnancy-associated lymphomas. A clinicopathologic study. Cancer 78(2), 304-310 (1996).
131. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer 79(5), 1004-1008 (1997).
132. Aviles A, Diaz-Maqueo JC, Torras V, Garcia EL, Guzman R. Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases. Gynecol. Oncol. 37(3), 335-337 (1990).
133. Devita VT Jr, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. Lippincott-Raven, PA, USA (1997).
134. Briggs GG. Drugs in Pregnancy and Lactation: a Reference Guide to Fetal and Neonatal Risk: Lippincott Williams Wilkins, MD, USA (1999).
135. Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit. Rev. Oncol. Hematol. 16(2), 75-112 (1994).
136. Shotton D, Monie IW. Possible teratogenic effect of chlorambucil on a human fetus. JAMA 186, 74-75 (1963).
137. Steege JF, Caldwell DS. Renal agenesis after first trimester exposure to chlorambucil. South Med. J. 73(10), 1414-1415 (1980).
138. Rugh R, Skaredoff L. Radiation and radiomimetric chlorambucil and the fetal retina. Arch. Ophthalmol. 74, 382-393 (1965).
139. Nicholson HO. Cytotoxic drugs in pregnancy. Review of reported cases. J. Obstet. Gynaecol. Br. Commonw. 75(3), 307-312 (1968).
140. Enns GM, Roeder E, Chan RT, Ali-Khan CZ, Cox VA, Golabi M. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am. J. Med. Genet. 86(3), 237-241 (1999).
141. Pizzuto J, Aviles A, Noriega L, Niz J, Morales M, Romero F. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat. Rep. 64(4-5), 679-683 (1980).
142. Gililland J, Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet. Gynecol. Surv. 38(1), 6-13 (1983).
143. Murray CL, Reichert JA, Anderson J, Twiggs LB. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 252(18), 2607-2608 (1984).
144. Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int. J. Gynecol. Cancer 12(4), 399-402 (2002).
145. Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am. J. Obstet. Gynecol. 183(2), 511-512 (2000).
146. Raffles A, Williams J, Costeloe K, Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. Br. J. Obstet. Gynaecol. 96(9), 1099-1100 (1989).
147. Warkany J. Aminopterin and methotrexate: folic acid deficiency. Teratology 17(3), 353-357 (1978).
148. Goetsch C. An evaluation of aminopterin as an abortifacient. Am. J. Obstet. Gynecol. 83, 1474-1477 (1962).
149. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum. 40(5), 971-973 (1997).
150. Milunsky A, Graef JW, Gaynor MF Jr. Methotrexate-induced congenital malformations. J. Pediatr. 72(6), 790-795 (1968).
151. Wagner VM, Hill JS, Weaver D, Baehner RL. Congenital abnormalities in baby born to cytarabine treated mother. Lancet 2(8185), 98-99 (1980).
152. Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. N. Engl. J. Med. 317(26), 1666-1667 (1987).
153. Volkenandt M, Buchner T, Hiddemann W, Van de Loo J. Acute leukaemia during pregnancy. Lancet 2(8574), 1521-1522 (1987).
154. Tomlinson MW, Treadwell MC, Deppe G. Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy. Eur. J. Gynaecol. Oncol. 18(1), 44-46 (1997).
155. Mendez LE, Mueller A, Salom E, Gonzalez-Quintero, VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet. Gynecol. 102(5 Pt 2), 1200-1202 (2003).
156. Gadducci A, Cosio S, Fanucchi A et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 23(6D), 5225-5229 (2003).
157. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH. Pregnancy outcome in cancer patients. Experience in a large co-operative group. Cancer 60(5), 1143-1150 (1987).
158. Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. Teratology 47(6), 533-539 (1993).